Amylin Pharmaceuticals (AMLN) announces that it completed a BLA submission to the FDA for the...

|By:, SA News Editor

Amylin Pharmaceuticals (AMLN) announces that it completed a BLA submission to the FDA for the use of metreleptin to treat diabetes and requested Priority Review from the agency for the drug.